310 related articles for article (PubMed ID: 17598505)
1. Organisation of cervical cytology screening in Croatia: past, present and future.
Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
[TBL] [Abstract][Full Text] [Related]
2. HPV testing for cervical cancer screening in Croatia.
Grce M; Grahovac B; Rukavina T; Vrdoljak-Mozetic D; Glavas-Obrovac L; Kaliterna V; Zele-Starcević L
Coll Antropol; 2007 Apr; 31 Suppl 2():67-71. PubMed ID: 17598507
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening programme in Primorsko-Goranska County, Croatia--the results of the pilot study.
Vrdoljak-Mozetic D; Ostojić DV; Stemberger-Papić S; Janković S; Glibotić-Kresina H; Brncić-Fischer A; Benić-Salamon K
Coll Antropol; 2010 Mar; 34(1):225-32. PubMed ID: 20437641
[TBL] [Abstract][Full Text] [Related]
4. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
Sepúlveda C; Prado R
Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
6. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
7. [Proposal of cervical cancer early detection programme in Croatia].
Znaor A; Babić D; Corusić A; Grce M; Mahovlić V; Pajtler M; Serman A
Lijec Vjesn; 2007 May; 129(5):158-63. PubMed ID: 17695198
[TBL] [Abstract][Full Text] [Related]
8. Liquid-based cytology for cervical cancer screening.
Bentz JS
Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
[TBL] [Abstract][Full Text] [Related]
9. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
10. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology.
Lazcano-Ponce E; Palacio-Mejia LS; Allen-Leigh B; Yunes-Diaz E; Alonso P; Schiavon R; Hernandez-Avila M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2808-17. PubMed ID: 18843027
[TBL] [Abstract][Full Text] [Related]
11. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Sankaranarayanan R; Budukh AM; Rajkumar R
Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
[TBL] [Abstract][Full Text] [Related]
12. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
Hølund B; Grinsted P
Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening in Thailand: an overview.
Sriamporn S; Khuhaprema T; Parkin M
J Med Screen; 2006; 13 Suppl 1():S39-43. PubMed ID: 17227641
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening among elderly urban women in a primary care setting.
Wong QC; Collins R; Kalkstein K; Roth A; Gintautas J
Proc West Pharmacol Soc; 2005; 48():154-6. PubMed ID: 16416686
[TBL] [Abstract][Full Text] [Related]
16. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
[TBL] [Abstract][Full Text] [Related]
17. Cervical cytology in vulnerable pregnant women.
Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening in Mediterranean countries: implications for the future.
Syrjänen K; Di Bonito L; Gonçalves L; Murjal L; Santamaria M; Mahovlic V; Karakitsos P; Onal B; Schmitt FC
Cytopathology; 2010 Dec; 21(6):359-67. PubMed ID: 20718841
[TBL] [Abstract][Full Text] [Related]
20. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
Arbyn M; Schenck U; Ellison E; Hanselaar A
Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
